36 reports

  • Sources of Capital: Japan Tissue Engineering Company Limited
  • SUMMARY ANALYSIS: Japan Tissue Engineering Company Limited

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company,...

  • Biological Therapy
  • Tissue Engineering
  • Japan
  • Company Financials

Tissue Engineering - Global Market Outlook (2017-2023) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Pr

  • Biological Therapy
  • Tissue Engineering
  • APAC
  • World
  • Forecast

Tissue Engineering Market Analysis and Forecast to 2021 Tissue engineering was the forerunner of the present regenerative medicine market.

  • Biological Therapy
  • Cell Therapy
  • Tissue Engineering
  • World
  • Market Size

Japan Tissue Engineering Co Ltd (##) - Financial and Strategic SWOT Analysis Review Section ## - About the Company Japan Tissue Engineering Co Ltd - Key Information Japan Tissue Engineering Co Ltd - Overview Japan Tissue

  • Biological Therapy
  • Tissue Engineering
  • Japan

Japan Tissue Engineering Co Ltd (##) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents ## List of Tables ## List of Figures ## Japan Tissue Engineering Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, ##

  • Tissue Engineering
  • Japan
  • M&A

Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview TABLE OF CONTENTS: PART A: GLOBAL MARKET PERSPECTIVE ##.

  • Tissue Engineering
  • Europe
  • United States
  • World
  • Market Shares

##.

  • Biological Therapy
  • Molecular Biology
  • Tissue Engineering
  • World
  • Market Shares
  • APPLICATION
  • Global Collagen Market Size for Regenerative Medicine, by Source (2017)

Global collagen & gelatin market for regenerative medicine projected to grow at a CAGR of 10.1% and 7.8% respectively. The global collagen market for regenerative medicine is projected to grow from USD 420.6 million in 2017 to USD 679.9 million by 2022, at a CAGR of 10.1% during the forecast period. The global gelatin market...

  • Tissue Engineering
  • Wound Care
  • North America
  • United States
  • Market Size
  • TISSUE ENGINEERING
  • Global Collagen Biomaterial Market, By Tissue Engineering, By Value

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Collagen Biomaterial Market on the basis of Source (Bovine, Porcine, Marine & Others), By Application (Tissue...

  • Tissue Engineering
  • North America
  • World
  • Market Size
  • Medtronic, Inc.
  • 7.1.3 TISSUE ENGINEERING
  • Regenerative Medicine Market: Revenue in USD billion, by Therapy Type, Germany, 2015-2023

The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period, 2018 to 2023. Currently, North America dominates the market due to rapid technological advancements. Increasing Adoption of Stem Cell Technology Increasing adoption...

  • Tissue Engineering
  • Acelity L.P. Inc.
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic, Inc.
  • 7.3 TISSUE ENGINEERING
  • 11.10 JAPAN TISSUE ENGINEERING CO., LTD. (SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)

“Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), By Product (Cell-Based, Acellular), By Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology)-Forecast To 2021” The global Regenerative medicine market is expected to reach USD 38.70 billion...

  • Molecular Biology
  • Tissue Engineering
  • North America
  • United States
  • Acelity L.P. Inc.

Global Translational Regenerative Medicine Market Prospects 2017-2027 ##.

  • Biological Therapy
  • Molecular Biology
  • Tissue Engineering
  • World
  • Forecast
  • TISSUE ENGINEERING
  • Indication

About Next-generation Biologics According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a “virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition...

  • Tissue Engineering
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Tissue Engineering ## Global Regenerative Medicines Market, by Product (Qualitative) ##. ##.

  • Biological Therapy
  • Biotechnology
  • Molecular Biology
  • Tissue Engineering
  • World

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering.

  • Biological Therapy
  • Molecular Biology
  • Tissue Engineering
  • World
  • Market Size

MARKET ##.

  • Biological Therapy
  • Biotechnology
  • Tissue Engineering
  • United States
  • World
  • HISTOGENICS ENTERS INTO LICENSING AGREEMENT WITH ADVANCED BIOMATRIX
  • Deal Type

Histogenics offers regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis.

  • Tissue Engineering
  • Japan
  • United States
  • Company
  • Histogenics Corporation

Approach ##: Commodity Flow & Bottom Up Approach ##. ##. ##.

  • Therapy
  • Tissue Engineering
  • United States
  • Forecast
  • Market Size
  • Market landscape
  • Global regenerative medicine market 2015-2020 ($ billions)

About the Regenerative Medicine Market Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy...

  • Tissue Engineering
  • Acelity L.P. Inc.
  • Medtronic, Inc.
  • Organogenesis, Inc.
  • Zimmer Biomet Holdings, Inc.
  • MARKET DRIVERS
  • INCREASING TECHNOLOGICAL ADVANCES

About Tissue Scaffolds Tissue scaffolds are cell growth supporting structures composed of natural or synthetic biocompatible materials that provide a favorable environment for cell proliferation and differentiation. Technavio’s analysts forecast the global tissue scaffolds market to grow at a CAGR of 12.14% during...

  • Tissue Engineering
  • World
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Smith & Nephew Plc
  • LICENSING AGREEMENTS

Histogenics offers regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis.

  • Tissue Engineering
  • Japan
  • United States
  • Company
  • Histogenics Corporation
  • LICENSING AGREEMENTS

Histogenics offers regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis.

  • Tissue Engineering
  • Japan
  • United States
  • Company
  • Histogenics Corporation

Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerative medicine approaches appears as the mos

  • Biological Therapy
  • Therapy
  • Tissue Engineering
  • World
  • Supply
  • Market Definition
  • OVERVIEW OF REGENERATIVE MEDICINE IN THE US MARKET

About Regenerative Medicine Market in the US Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative...

  • Tissue Engineering
  • United States
  • Acelity L.P. Inc.
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Hair transplant physicians
  • 3.3.3 Global Biopreservation Media Market by Value

Scope of the Report The report titled “Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global biopreservation market by value and by segments. The report provides an analysis of the biopreservation market by region: North America and Asia-Pacific. The report also...

  • Tissue Engineering
  • World
  • BioLife Solutions, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.

You can request one free hour of our analyst’s time when you purchase this market report.

  • Biological Therapy
  • Biotechnology
  • Molecular Biology
  • Tissue Engineering
  • Japan

Bursac' s cutting-edge technology relating to cardiac electrophysiology and cardiac tissue engineering will permit us to use micro-patterned cardiac tissue to significantly expand the approaches we use in our drug rescue programs to quantify drug effects on functional

  • Therapy
  • Tissue Engineering
  • United States
  • Company
  • VistaGen Therapeutics, Inc.
  • Global biopreservation market by regenerative medicine 2016-2021 ($ millions)
  • GLOBAL BIOPRESERVATION MARKET BY REGENERATIVE MEDICINE

It is also used in production of artificial organs and tissue engineering.

  • Tissue Engineering
  • World
  • BioLife Solutions, Inc.
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

Each unit will consist of one share of common stock one-half of one warrant to purchase one share of common stock.

  • Pharmaceutical
  • Tissue Engineering
  • United States
  • Company Financials
  • BioLife Solutions, Inc.
  • Unique Considerations for Common Cell-Based Bioprinting Applications
  • 4.3 MAJOR UNIVERSITIES AND ASSOCIATIONS IN 3D BIOPRINTING RESEARCH

One of the most important factors that decide the success of tissue engineering is the choice of suitable cells, assuring persistence and function of the regenerated tissue for the patient' s life time.

  • Tissue Engineering
  • United States
  • Demand
  • EnvisionTEC GmbH
  • Organovo Holdings, Inc.